Facilities & Capabilities
Salient Features - Overall Manufacturing Facility
![](https://dashapharma.com/wp-content/uploads/2022/12/layout.png)
- 220 KL reaction volume reactors with an even mix of glass lined and stainless-steel reactors; with a provision for another 800 KL reaction capac
- Supported with sufficient auxiliary systems like filters, dryers, vacuum systems
- A separate Kilo lab to support new products scale-up
- Utilities needed for all range of unit operations
- GMP compliant Quality control lab; which includes chemical testing lab, instrumentation lab, stability chambers and reserved samples storage (Provision for Microbiology lab in future).
- Comprehensive warehousing facility with cGMP norms, for raw materials, packing materials, bulk solvents, intermediates and finished product.
- Solvent recovery system with reboilers, condensers and distillation columns to effectively manage solvents.
- A complete Waste Management system, which includes Zero Liquid Discharge (ZLD) unit to manage high TDS streams, RO for low TDS, solid waste
management, scrubbers for acidic vapors. - OHC, Training hall, Cafeteria, Safe document storage system.
Salient Features - ONCO Facility
✓ 15 KL reaction volume reactors with an even mix of glass lined and stainless-steel reactors (100L, 250L, 500l, 1KL reactors)
✓ Advanced Negative Pressure Isolator System- Such as RTP transfer system, PUSH-PUSH filter system, Half-body clothing and other equipment
✓ Regular online Monitoring – Dust Test for Isolator & Air monitoring.
✓ Perfect SOP and Training system for high potency production – Safe handling of OEB3 & OEB5 compounds.
✓ Ongoing performance monitoring.
✓ Rigorous training for handling potent compounds.
✓ Capabilities are designed to reduce the risk posed by these toxic substances.
✓ Configured our equipments to maximize flexibility and developed processes to eliminate contamination vectors, like pressurization
![](https://dashapharma.com/wp-content/uploads/2022/12/salient.png)
![](https://dashapharma.com/wp-content/uploads/2022/12/features.png)